KRAS: Deciphering the Mechanism of Resistance To First Generation KRAS Inhibitors
By: Karen Reckamp, MD
KRAS: Deciphering the Mechanism of Resistance To First Generation KRAS Inhibitors
By: Karen Reckamp, MD
Toxicity Management of Novel Agents in Lung Cancer (RET, MET & KRAS G-12)
By: Khurrum Qureshi, PharmD, BCOP
Toxicity Management of Novel Agents in Lung Cancer (RET, MET & KRAS G-12)
By: Khurrum Qureshi, PharmD, BCOP